Gilead Sciences, Inc. (GILD)
USD 90.69
(-2.27%)
USD 90.69
(-2.27%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 27.11 Billion USD | -0.6% |
| 2022 | 27.28 Billion USD | -0.09% |
| 2021 | 27.3 Billion USD | 10.6% |
| 2020 | 24.68 Billion USD | 9.98% |
| 2019 | 22.44 Billion USD | 1.46% |
| 2018 | 22.12 Billion USD | -15.24% |
| 2017 | 26.1 Billion USD | -14.09% |
| 2016 | 30.39 Billion USD | -6.89% |
| 2015 | 32.63 Billion USD | 31.13% |
| 2014 | 24.89 Billion USD | 122.2% |
| 2013 | 11.2 Billion USD | 15.45% |
| 2012 | 9.7 Billion USD | 15.71% |
| 2011 | 8.38 Billion USD | 5.48% |
| 2010 | 7.94 Billion USD | 13.38% |
| 2009 | 7.01 Billion USD | 31.4% |
| 2008 | 5.33 Billion USD | 26.14% |
| 2007 | 4.23 Billion USD | 39.78% |
| 2006 | 3.02 Billion USD | 49.19% |
| 2005 | 2.02 Billion USD | 53.13% |
| 2004 | 1.32 Billion USD | 52.63% |
| 2003 | 867.86 Million USD | 85.92% |
| 2002 | 466.79 Million USD | 99.68% |
| 2001 | 233.76 Million USD | 19.54% |
| 2000 | 195.55 Million USD | 15.71% |
| 1999 | 169 Million USD | 418.4% |
| 1998 | 32.6 Million USD | -18.5% |
| 1997 | 40 Million USD | 19.76% |
| 1996 | 33.4 Million USD | 1137.04% |
| 1995 | 2.7 Million USD | -34.15% |
| 1994 | 4.1 Million USD | 0.0% |
| 1992 | 4.2 Million USD | 50.0% |
| 1991 | 2.8 Million USD | 115.38% |
| 1990 | 1.3 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 6.68 Billion USD | -6.03% |
| 2024 Q2 | 6.94 Billion USD | 3.93% |
| 2023 Q4 | 7.11 Billion USD | 0.92% |
| 2023 Q1 | 6.35 Billion USD | -14.03% |
| 2023 FY | 27.11 Billion USD | -0.6% |
| 2023 Q2 | 6.59 Billion USD | 3.89% |
| 2023 Q3 | 7.05 Billion USD | 6.83% |
| 2022 Q3 | 7.04 Billion USD | 12.49% |
| 2022 Q2 | 6.26 Billion USD | -5.01% |
| 2022 FY | 27.28 Billion USD | -0.09% |
| 2022 Q4 | 7.38 Billion USD | 4.93% |
| 2022 Q1 | 6.59 Billion USD | -9.03% |
| 2021 FY | 27.3 Billion USD | 10.6% |
| 2021 Q1 | 6.42 Billion USD | -13.45% |
| 2021 Q2 | 6.21 Billion USD | -3.21% |
| 2021 Q3 | 7.42 Billion USD | 19.37% |
| 2021 Q4 | 7.24 Billion USD | -2.39% |
| 2020 Q1 | 5.54 Billion USD | -5.63% |
| 2020 Q2 | 5.14 Billion USD | -7.3% |
| 2020 Q4 | 7.42 Billion USD | 12.83% |
| 2020 FY | 24.68 Billion USD | 9.98% |
| 2020 Q3 | 6.57 Billion USD | 27.88% |
| 2019 Q4 | 5.87 Billion USD | 4.91% |
| 2019 Q1 | 5.28 Billion USD | -8.87% |
| 2019 FY | 22.44 Billion USD | 1.46% |
| 2019 Q3 | 5.6 Billion USD | -1.42% |
| 2019 Q2 | 5.68 Billion USD | 7.65% |
| 2018 Q4 | 5.79 Billion USD | 3.56% |
| 2018 FY | 22.12 Billion USD | -15.24% |
| 2018 Q3 | 5.59 Billion USD | -0.92% |
| 2018 Q2 | 5.64 Billion USD | 11.01% |
| 2018 Q1 | 5.08 Billion USD | -14.47% |
| 2017 Q4 | 5.94 Billion USD | -8.65% |
| 2017 Q1 | 6.5 Billion USD | -11.13% |
| 2017 FY | 26.1 Billion USD | -14.09% |
| 2017 Q2 | 7.14 Billion USD | 9.78% |
| 2017 Q3 | 6.51 Billion USD | -8.81% |
| 2016 Q2 | 7.77 Billion USD | -0.23% |
| 2016 FY | 30.39 Billion USD | -6.89% |
| 2016 Q1 | 7.79 Billion USD | -8.37% |
| 2016 Q3 | 7.5 Billion USD | -3.55% |
| 2016 Q4 | 7.32 Billion USD | -2.4% |
| 2015 Q4 | 8.5 Billion USD | 2.54% |
| 2015 Q3 | 8.29 Billion USD | 0.62% |
| 2015 Q2 | 8.24 Billion USD | 8.56% |
| 2015 Q1 | 7.59 Billion USD | 3.83% |
| 2015 FY | 32.63 Billion USD | 31.13% |
| 2014 FY | 24.89 Billion USD | 122.2% |
| 2014 Q4 | 7.31 Billion USD | 21.06% |
| 2014 Q3 | 6.04 Billion USD | -7.55% |
| 2014 Q1 | 4.99 Billion USD | 60.23% |
| 2014 Q2 | 6.53 Billion USD | 30.73% |
| 2013 Q3 | 2.78 Billion USD | 0.56% |
| 2013 FY | 11.2 Billion USD | 15.45% |
| 2013 Q1 | 2.53 Billion USD | -2.19% |
| 2013 Q2 | 2.76 Billion USD | 9.31% |
| 2013 Q4 | 3.11 Billion USD | 12.11% |
| 2012 FY | 9.7 Billion USD | 15.71% |
| 2012 Q4 | 2.58 Billion USD | 6.66% |
| 2012 Q3 | 2.42 Billion USD | 0.89% |
| 2012 Q2 | 2.4 Billion USD | 5.38% |
| 2012 Q1 | 2.28 Billion USD | 3.73% |
| 2011 FY | 8.38 Billion USD | 5.48% |
| 2011 Q4 | 2.2 Billion USD | 3.71% |
| 2011 Q3 | 2.12 Billion USD | -0.73% |
| 2011 Q2 | 2.13 Billion USD | 10.96% |
| 2011 Q1 | 1.92 Billion USD | -3.63% |
| 2010 Q2 | 1.92 Billion USD | -7.6% |
| 2010 Q3 | 1.93 Billion USD | 0.54% |
| 2010 FY | 7.94 Billion USD | 13.38% |
| 2010 Q4 | 1.99 Billion USD | 3.15% |
| 2010 Q1 | 2.08 Billion USD | 2.63% |
| 2009 FY | 7.01 Billion USD | 31.4% |
| 2009 Q2 | 1.64 Billion USD | 7.62% |
| 2009 Q3 | 1.8 Billion USD | 9.36% |
| 2009 Q4 | 2.03 Billion USD | 12.82% |
| 2009 Q1 | 1.53 Billion USD | 7.16% |
| 2008 Q4 | 1.42 Billion USD | 4.15% |
| 2008 Q3 | 1.37 Billion USD | 7.29% |
| 2008 Q2 | 1.27 Billion USD | 1.59% |
| 2008 Q1 | 1.25 Billion USD | 14.93% |
| 2008 FY | 5.33 Billion USD | 26.14% |
| 2007 Q3 | 1.05 Billion USD | 1.02% |
| 2007 Q4 | 1.09 Billion USD | 3.39% |
| 2007 Q2 | 1.04 Billion USD | 1.91% |
| 2007 Q1 | 1.02 Billion USD | 14.37% |
| 2007 FY | 4.23 Billion USD | 39.78% |
| 2006 FY | 3.02 Billion USD | 49.19% |
| 2006 Q2 | 685.3 Million USD | -1.09% |
| 2006 Q1 | 692.87 Million USD | 13.72% |
| 2006 Q3 | 748.73 Million USD | 9.26% |
| 2006 Q4 | 899.22 Million USD | 20.1% |
| 2005 Q1 | 430.41 Million USD | 16.46% |
| 2005 FY | 2.02 Billion USD | 53.13% |
| 2005 Q4 | 609.26 Million USD | 23.47% |
| 2005 Q3 | 493.45 Million USD | -0.37% |
| 2005 Q2 | 495.26 Million USD | 15.07% |
| 2004 Q1 | 309.12 Million USD | 17.31% |
| 2004 Q3 | 326.18 Million USD | 2.02% |
| 2004 Q4 | 369.58 Million USD | 13.3% |
| 2004 Q2 | 319.72 Million USD | 3.43% |
| 2004 FY | 1.32 Billion USD | 52.63% |
| 2003 Q1 | 165.1 Million USD | 13.84% |
| 2003 Q4 | 263.51 Million USD | 31.51% |
| 2003 Q2 | 238.87 Million USD | 44.68% |
| 2003 Q3 | 200.37 Million USD | -16.12% |
| 2003 FY | 867.86 Million USD | 85.92% |
| 2002 Q4 | 145.02 Million USD | 8.24% |
| 2002 FY | 466.79 Million USD | 99.68% |
| 2002 Q2 | 109.36 Million USD | 39.47% |
| 2002 Q3 | 133.98 Million USD | 22.51% |
| 2002 Q1 | 78.41 Million USD | 5.5% |
| 2001 Q1 | 57.83 Million USD | 4.65% |
| 2001 Q3 | 50.91 Million USD | 0.45% |
| 2001 Q2 | 50.68 Million USD | -12.36% |
| 2001 FY | 233.76 Million USD | 19.54% |
| 2001 Q4 | 74.33 Million USD | 45.99% |
| 2000 Q1 | 45.22 Million USD | -7.33% |
| 2000 FY | 195.55 Million USD | 15.71% |
| 2000 Q2 | 49.97 Million USD | 10.52% |
| 2000 Q3 | 45.08 Million USD | -9.78% |
| 2000 Q4 | 55.26 Million USD | 22.57% |
| 1999 Q2 | 8.7 Million USD | 77.55% |
| 1999 Q3 | 38.4 Million USD | 341.38% |
| 1999 Q4 | 48.8 Million USD | 27.08% |
| 1999 FY | 169 Million USD | 418.4% |
| 1999 Q1 | 4.9 Million USD | -45.56% |
| 1998 Q3 | 3 Million USD | -57.14% |
| 1998 Q1 | 13.6 Million USD | 37.37% |
| 1998 Q2 | 7 Million USD | -48.53% |
| 1998 Q4 | 9 Million USD | 200.0% |
| 1998 FY | 32.6 Million USD | -18.5% |
| 1997 Q4 | 9.9 Million USD | 102.04% |
| 1997 Q2 | 19.7 Million USD | 258.18% |
| 1997 Q1 | 5.5 Million USD | -5.17% |
| 1997 FY | 40 Million USD | 19.76% |
| 1997 Q3 | 4.9 Million USD | -75.13% |
| 1996 Q3 | 24.7 Million USD | 1022.73% |
| 1996 FY | 33.4 Million USD | 1137.04% |
| 1996 Q4 | 5.8 Million USD | -76.52% |
| 1996 Q2 | 2.2 Million USD | 175.0% |
| 1996 Q1 | 800 Thousand USD | 0.0% |
| 1995 Q2 | 900 Thousand USD | 0.0% |
| 1995 Q3 | 1.1 Million USD | 22.22% |
| 1995 FY | 2.7 Million USD | -34.15% |
| 1995 Q1 | 900 Thousand USD | -30.77% |
| 1994 Q3 | 1.6 Million USD | 45.45% |
| 1994 Q4 | 1.3 Million USD | -18.75% |
| 1994 FY | 4.1 Million USD | 0.0% |
| 1994 Q1 | 1.1 Million USD | 0.0% |
| 1994 Q2 | 1.1 Million USD | 0.0% |
| 1993 Q4 | 1.1 Million USD | 10.0% |
| 1993 Q1 | 1 Million USD | 0.0% |
| 1993 Q2 | 1 Million USD | 0.0% |
| 1993 Q3 | 1 Million USD | 0.0% |
| 1992 FY | 4.2 Million USD | 50.0% |
| 1992 Q4 | 1 Million USD | 0.0% |
| 1992 Q3 | 1 Million USD | -9.09% |
| 1992 Q2 | 1.1 Million USD | -42.11% |
| 1992 Q1 | 1.9 Million USD | 280.0% |
| 1991 Q1 | 1.2 Million USD | 1100.0% |
| 1991 Q2 | 200 Thousand USD | -83.33% |
| 1991 Q3 | 200 Thousand USD | 0.0% |
| 1991 Q4 | 500 Thousand USD | 150.0% |
| 1991 FY | 2.8 Million USD | 115.38% |
| 1990 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q2 | 100 Thousand USD | 0.0% |
| 1990 Q4 | 100 Thousand USD | 0.0% |
| 1990 FY | 1.3 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Amgen Inc. | 28.19 Billion USD | 3.81% |
| AstraZeneca PLC | 45.81 Billion USD | 40.809% |
| Biogen Inc. | 9.83 Billion USD | -175.692% |
| MIRA Pharmaceuticals, Inc. | - USD | -Infinity% |
| Scilex Holding Company | 46.74 Million USD | -57910.825% |
| Scilex Holding Company | 46.74 Million USD | -57910.825% |